Zhujiang Hospital

Running trials

• Recruiting

  Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma

  NCT06902012· Phase 1/2· Source

• Not yet recruiting

  A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes

  NCT07881432· Phase 3· Source

• Not yet recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

  NCT07900633· Phase 3· Source

• Not yet recruiting

  A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems

  NCT07790861· Phase 3· Source

• Not yet recruiting

  Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia

  NCT07696481· Early phase 1· Source

• Recruiting

  AI-Driven Metabolic Cohort in Overweight/Obese Chinese Adults

  NCT07584330· Source

• Not yet recruiting

  Hexaminolevulinate Photodynamic Therapy (HAL-PDT) With Deferred Surgery Versus Surgery for High-grade Squamous Intraepithelial Lesions (HSIL)

  NCT07669363· Phase 2· Source

• Not yet recruiting

  Multicenter Prospective Validation of AI Models for Malignancy Risk Prediction in Pulmonary Nodules

  NCT07727122· Source

• Recruiting

  Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP

  NCT07380113· Phase 4· Source

• Recruiting

  A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

  NCT07525206· Phase 3· Source

• Recruiting

  Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

  NCT07632677· Source

• Not yet recruiting

  Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

  NCT07457099· Source

• Recruiting

  Early Complications After Flow Diverter Versus Stent-Assisted Coiling for Unruptured Wide-Neck Intracranial Bifurcation Aneurysms

  NCT07754188· Source

• Recruiting

  A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  NCT07392190· Phase 3· Source

• Recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  NCT07321886· Phase 3· Source

• Not yet recruiting

  Cerebral Arteriovenous Malformation With Aneurysm: Epidemiology, Clinical Features, and Prognosis

  NCT07353736· Source

• Active, not recruiting

  Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma

  NCT07686575· Source

• Recruiting

  A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

  NCT07347600· Source

• Recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  NCT07282600· Phase 3· Source

• Recruiting

  A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  NCT07218380· Phase 3· Source

• Recruiting

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  NCT07241390· Phase 3· Source

• Recruiting

  A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  NCT07213804· Phase 3· Source

• Recruiting

  Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  NCT07106762· Phase 2/3· Source

• Recruiting

  A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

  NCT07202884· Phase 3· Source

• Recruiting

  Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion

  NCT07170345· Source

• Recruiting

  CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study

  NCT07072494· Phase 1/2· Source

• Active, not recruiting

  A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes

  NCT06972472· Phase 3· Source

• Active, not recruiting

  A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

  NCT06972459· Phase 3· Source

• Active, not recruiting

  A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes

  NCT06993792· Phase 3· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819891· Phase 3· Source

• Recruiting

  Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting

  NCT06726460· Source

• Recruiting

  Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence

  NCT06644937· Phase 2/3· Source

• Active, not recruiting

  A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

  NCT06653153· Phase 3· Source

• Active, not recruiting

  Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06564142· Phase 3· Source

• Active, not recruiting

  Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

  NCT06492291· Phase 3· Source

• Recruiting

  RC48 Combined With Toripalimab as Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients

  NCT06341400· Phase 1/2· Source

• Recruiting

  The Correlation of Intracranial Artery Calcification and Outcomes of Mechanical Thrombectomy

  NCT06418698· Source

• Active, not recruiting

  A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma

  NCT05954910· Source

• Recruiting

  A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC

  NCT07133958· Source

• Recruiting

  A Study on the Correlation Between Endometriosis and Intra-tissue Microbiota

  NCT06266897· Source

• Recruiting

  A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China

  NCT05445544· Source

• Recruiting

  Pipeline Embolization for Intracranial Aneurysms

  NCT06446778· Source

• Active, not recruiting

  A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

  NCT05458297· Phase 2· Source

• Recruiting

  A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

  NCT05139017· Phase 2/3· Source

• Active, not recruiting

  Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).

  NCT05116189· Phase 3· Source

• Recruiting

  Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects

  NCT04861584· Phase 2· Source

• Active, not recruiting

  A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)

  NCT05058040· Phase 4· Source

• Recruiting

  Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder

  NCT03108196· Source

• Recruiting

  Epidemiological Insights Into the Formation, Progression, and Rupture of Intracranial Aneurysms: A Retrospective, Multi-Center Hospital-Based Study in China

  NCT06456814· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity8 recruiting
• Type 2 diabetes7 recruiting
• Bladder cancer5 recruiting
• Brain aneurysm4 recruiting
• Stroke4 recruiting
• Childhood cancers3 recruiting
• Acute lymphoblastic leukaemia2 recruiting
• Head and neck cancer2 recruiting
• Liver and biliary tract cancer2 recruiting
• Acute myeloid leukaemia1 recruiting
• Cervical cancer1 recruiting
• Chronic kidney disease1 recruiting
• Colorectal cancer1 recruiting
• Crohn's disease1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Endometriosis1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Metastatic breast cancer1 recruiting
• Ovarian cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Ultrasound-guided Injection of Glucocorticoid Into Infrapatellar Fat Pad in Patients With Knee Osteoarthritis

  NCT05291650· Phase 4· Source

• Completed

  HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study

  NCT04694495· Source

• Completed

  The Correlation Between CITED2 and Collateral Circulation in Acute Ischemic Stroke

  NCT05345366· Source

• Completed

  A Study of Ninlaro in Real World Clinical Practice in China

  NCT04328662· Source

• Completed

  A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

  NCT04102098· Phase 3· Source

• Completed

  Methotrexate in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitis

  NCT03815448· Source

• Completed

  Infrapatellar Fat Pad Preservation Versus Resection on Clinical Outcomes After Total Knee Arthroplasty(IPAKA)

  NCT03763448· Source

• Completed

  Safety and Efficacy of Stent Deployment for Intracranial Aneurysms (SESIA)

  NCT03387995· Source

Trial sites

• Department of Endocrinology, Zhujiang Hospital, Southern Medical University1 trial
• Department of Hematology, Zhujiang Hospital, Southern Medical University1 trial
• Department of Stomatology, Zhujiang Hospital, Southern Medical University,Guangzhou, Guangdong1 trial
• Department of Stomatology, Zhujiang Hospital, Southern Medical University,Haizhu District1 trial
• Department of Stomatology, Zhujiang Hospital, Southern Medical University, Haizhu District, Guangzhou1 trial
• Department of Stomatology, Zhujiang Hospital, Southern Medical University, Haizhu District, Guangzhou, Guangzhou, Guangdong 5102821 trial
• Zhujiang Hospital30 trials
• Zhujiang Hospital /ID# 2796671 trial
• Zhujiang Hospital (Site 0739)1 trial
• Zhujiang Hospital (Site 1207)1 trial
• Zhujiang Hospital (Site 3002)1 trial
• Zhujiang Hospital (Site 6029)1 trial
• Zhujiang Hospital, Southern Medical University15 trials
• Zhujiang Hospital, Southern Medical University, No. 253 Gongye Road, Guangzhou, 510282, China1 trial
• Zhujiang Hospital, Southern Medical University Organization1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Osteoarthritis58 works · 3 trials
• Brain aneurysm18 works · 5 trials
• Acute lymphoblastic leukaemia16 works · 2 trials
• Gout6 works · 0 trials
• Vascular dementia4 works · 0 trials